enVVeno Medical Corp Federal Income Tax Expense (Benefit), Continuing Operations
enVVeno Medical Corp (NVNO) reported Federal Income Tax Expense (Benefit), Continuing Operations of $45.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2022-03-28
- enVVeno Medical Corp federal income tax expense (benefit), continuing operations for fiscal 2021 was $45.70M, a 30.57% increase from fiscal 2020.
- enVVeno Medical Corp federal income tax expense (benefit), continuing operations for fiscal 2020 was $35.00M.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2021-12-31 | $45.70M 10-K · filed 2022-03-28 |
| 2020-12-31 | $35.00M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |